Gapping up
In reaction to earnings/guidance:
- GTEC +8.3%, SIG +4.3% (raises guidance), UBER +2.2% (guidance)
Select Biotech/Pharma related names showing strength following AACR conference:
- CRDF +7.3%, CMPI +6.9%, ZNTL +5.6%, TIL +5%, SPPI +4.2%, LYRA +4%, NCNA +3.9%, AFMD +3.7%, KZR +3%, AGEN +2.3%, ITOS +1.8%, ACHL +1.7%, ONCY +1.7%, SYBX +1.5%, REGN +1.4%, CLVS +1.3%
Other news:
- NUAN +23.3% (Microsoft is in advanced talks to buy Nuance Communications (NUAN) at about $56/share)
- CADE +7.3% (BancorpSouth and Cadence Bancorporation (CADE) merge in all stock deal worth more than $6 bln)
- TSHA +6.6% (acquire exclusive worldwide rights to a clinical-stage AAV9 gene therapy program for the treatment of giant axonal neuropathy)
- BABA +6.2% (receives Administrative Penalty Decision issued by the State Administration for Market Regulation of the People's Republic of China)
- SJ +6.2% (established a strategic partnership with Fujian Chuanzheng Communications College and Hangzhou Liyumen Technology Development to establish a broadcaster training academy for live stream entertainment and e-commerce)
- IR +4.8% (sells Club Car to Platinum Equity for $1.68 bln)
- FGEN +4.2% (granted Fast Track designation for the company's anti-CTGF antibody, pamrevlumab, for the treatment of patients with Duchenne muscular dystrophy)
- WTRE +2.9% (announces acquisition of Axeria IARD; terms not disclosed)
- UBER +2.3% (files for 1,561,341 share common stock offering by selling shareholders)
- FTFT +2.3% (amends its Share Exchange Agreement with Joy Rich Enterprises to acquire 90% of the issued and outstanding shares of Nice Talent Asset Management)
- EGY +2.2% (names George Maxwell CEO)
- CYTK +1.6% (present data related to the optimization of CK-3773274 (CK-274), including the first disclosure of its chemical structure)
- MRNS +1.2% (appoints Steven Pfanstiel as Chief Financial Officer)
Analyst comments:
- TREX +3.1% (upgraded to Buy from Hold at Truist)
- MTCH +1.6% (upgraded to Buy from Neutral at BTIG Research)
- TSLA +1.4% (upgraded to Buy from Hold at Canaccord Genuity)
- LYG +1.3% (upgraded to Buy from Hold at Deutsche Bank)
- CMG +1.1% (upgraded to Outperform from Mkt Perform at Raymond James)